Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Another Johnson & Johnson drug plant gets flagged
CNN Money
Saturday, July 17, 2010 - 10:00am
tags:
JNJ, recalls
A Positive Sign for Pharma Earnings Season
Motley Fool
Saturday, July 17, 2010 - 9:57am
tags:
investors
Medicine Recall 2010: Photos of Recalled J&J Products
The Street
Saturday, July 17, 2010 - 9:56am
tags:
JNJ, recalls
A Queasy Feeling Over Big Pharma
Financial Times
Saturday, July 17, 2010 - 9:55am
tags:
AstraZeneca, Merck, Pfizer, JNJ, GSK
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients
Yahoo/PR NewsWire
Saturday, July 17, 2010 - 9:52am
tags:
Amgen, denosumab, skeletal metastases
Gilead shares fall on pipeline concerns
MarketWatch
Saturday, July 17, 2010 - 9:49am
tags:
Gilead Sciences
Anonymous Email Slams Dendreon Stockholders
Forbes
Saturday, July 17, 2010 - 9:47am
tags:
Dendreon, Provenge, investors
Vivus tanks, Arena rallies on FDA diet-drug vote
Marketwatch
Friday, July 16, 2010 - 10:05am
tags:
Vivus, Arena Pharmaceuticals, FDA, Orexigen, Contrave, Qnexa
Should J&J Replace The McNeil Management Team?
Pharmalot
Friday, July 16, 2010 - 9:48am
tags:
JNJ, Tylenol, recalls
Warner Chilcott says FDA extends drug review
Yahoo/AP
Friday, July 16, 2010 - 9:46am
tags:
FDA, Warner Chilcott, Actonel
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Star Ledger, NJ
Friday, July 16, 2010 - 9:26am
tags:
FDA, cancer, ARBs, Merck, Cozaar, Bristol-Myers Squibb, Avapro, Atacand, Benicar, Diovan, Micardis, Teveten
Elan to settle Zonegran investigation for $204M
Bloomberg Businessweek
Friday, July 16, 2010 - 9:20am
tags:
Zonegran, Elan, settlements, epilepsy
Mylan buys $550m passport to US injectables market
InPharmaTechnologist
Friday, July 16, 2010 - 9:16am
tags:
Mylan, M&A, injectables, Bioniche Pharma
Vernalis Parkinson's drug sinks on tox issues
Fierce Biotech
Friday, July 16, 2010 - 9:14am
tags:
Vernalis, Parkinson's Disease, Biogen Idec, vipadenant
Adolor to cut 30 jobs as Entereg sales disappoint
Yahoo/AP
Friday, July 16, 2010 - 9:12am
tags:
Adolor, layoffs, Entereg
Can Eisai's new Alzheimer's drug fill blockbuster shoes?
Fierce Biotech
Friday, July 16, 2010 - 8:40am
tags:
Eisai, Alzheimer's disease, Pfizer, Aricept
Cancer Vaccines: Northwest Biotherapeutics vs. Dendreon
Seeking Alpha
Friday, July 16, 2010 - 8:37am
tags:
Dendreon, vaccines, cancer, Northwest Biotherapeutics
Healthcare's Biggest Loser This Year: Abbott
CNBC
Friday, July 16, 2010 - 8:36am
tags:
Abbott Laboratories
Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Bloomberg
Friday, July 16, 2010 - 8:23am
tags:
FDA, Avastin, Roche, breast cancer
Alexion Hoping Its Soliris Is That Rare Wonder Drug
Investors.com
Friday, July 16, 2010 - 8:22am
tags:
Alexion, Soliris, PNH

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.